Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial

Z. Czigany, D. Uluk, S. Pavicevic, I. Lurje, J. Froněk, T. Keller, P. Strnad, D. Jiang, T. Gevers, D. Koliogiannis, M. Guba, RH. Tolba, FA. Meister, UP. Neumann, M. Kocik, M. Kysela, IM. Sauer, N. Raschzok, W. Schöning, I. Popescu, F. Tacke, J....

. 2024 ; 8 (2) : . [pub] 20240203

Language English Country United States

Document type Randomized Controlled Trial, Multicenter Study, Journal Article

Persistent link   https://www.medvik.cz/link/bmc24007205

BACKGROUND: While 4 randomized controlled clinical trials confirmed the early benefits of hypothermic oxygenated machine perfusion (HOPE), high-level evidence regarding long-term clinical outcomes is lacking. The aim of this follow-up study from the HOPE-ECD-DBD trial was to compare long-term outcomes in patients who underwent liver transplantation using extended criteria donor allografts from donation after brain death (ECD-DBD), randomized to either HOPE or static cold storage (SCS). METHODS: Between September 2017 and September 2020, recipients of liver transplantation from 4 European centers receiving extended criteria donor-donation after brain death allografts were randomly assigned to HOPE or SCS (1:1). Follow-up data were available for all patients. Analyzed endpoints included the incidence of late-onset complications (occurring later than 6 months and graded according to the Clavien-Dindo Classification and the Comprehensive Complication Index) and long-term graft survival and patient survival. RESULTS: A total of 46 patients were randomized, 23 in both arms. The median follow-up was 48 months (95% CI: 41-55). After excluding early perioperative morbidity, a significant reduction in late-onset morbidity was observed in the HOPE group (median reduction of 23 Comprehensive Complication Index-points [p=0.003] and lower incidence of major complications [Clavien-Dindo ≥3, 43% vs. 85%, p=0.009]). Primary graft loss occurred in 13 patients (HOPE n=3 vs. SCS n=10), resulting in a significantly lower overall graft survival (p=0.029) and adverse 1-, 3-, and 5-year survival probabilities in the SCS group, which did not reach the level of significance (HOPE 0.913, 0.869, 0.869 vs. SCS 0.783, 0.606, 0.519, respectively). CONCLUSIONS: Our exploratory findings indicate that HOPE reduces late-onset morbidity and improves long-term graft survival providing clinical evidence to further support the broad implementation of HOPE in human liver transplantation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007205
003      
CZ-PrNML
005      
20240423155805.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HC9.0000000000000376 $2 doi
035    __
$a (PubMed)38315126
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Czigany, Zoltan $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany $u Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany $1 https://orcid.org/0000000303733210
245    10
$a Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial / $c Z. Czigany, D. Uluk, S. Pavicevic, I. Lurje, J. Froněk, T. Keller, P. Strnad, D. Jiang, T. Gevers, D. Koliogiannis, M. Guba, RH. Tolba, FA. Meister, UP. Neumann, M. Kocik, M. Kysela, IM. Sauer, N. Raschzok, W. Schöning, I. Popescu, F. Tacke, J. Pratschke, G. Lurje
520    9_
$a BACKGROUND: While 4 randomized controlled clinical trials confirmed the early benefits of hypothermic oxygenated machine perfusion (HOPE), high-level evidence regarding long-term clinical outcomes is lacking. The aim of this follow-up study from the HOPE-ECD-DBD trial was to compare long-term outcomes in patients who underwent liver transplantation using extended criteria donor allografts from donation after brain death (ECD-DBD), randomized to either HOPE or static cold storage (SCS). METHODS: Between September 2017 and September 2020, recipients of liver transplantation from 4 European centers receiving extended criteria donor-donation after brain death allografts were randomly assigned to HOPE or SCS (1:1). Follow-up data were available for all patients. Analyzed endpoints included the incidence of late-onset complications (occurring later than 6 months and graded according to the Clavien-Dindo Classification and the Comprehensive Complication Index) and long-term graft survival and patient survival. RESULTS: A total of 46 patients were randomized, 23 in both arms. The median follow-up was 48 months (95% CI: 41-55). After excluding early perioperative morbidity, a significant reduction in late-onset morbidity was observed in the HOPE group (median reduction of 23 Comprehensive Complication Index-points [p=0.003] and lower incidence of major complications [Clavien-Dindo ≥3, 43% vs. 85%, p=0.009]). Primary graft loss occurred in 13 patients (HOPE n=3 vs. SCS n=10), resulting in a significantly lower overall graft survival (p=0.029) and adverse 1-, 3-, and 5-year survival probabilities in the SCS group, which did not reach the level of significance (HOPE 0.913, 0.869, 0.869 vs. SCS 0.783, 0.606, 0.519, respectively). CONCLUSIONS: Our exploratory findings indicate that HOPE reduces late-onset morbidity and improves long-term graft survival providing clinical evidence to further support the broad implementation of HOPE in human liver transplantation.
650    _2
$a lidé $7 D006801
650    12
$a transplantace jater $x škodlivé účinky $7 D016031
650    _2
$a následné studie $7 D005500
650    _2
$a mozková smrt $7 D001926
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a perfuze $x metody $7 D010477
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Uluk, Deniz $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $1 https://orcid.org/0000000163950845
700    1_
$a Pavicevic, Sandra $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $1 https://orcid.org/0000000162042466
700    1_
$a Lurje, Isabella $u Department of Hepatology and Gastroenterology, Campus Charité Mitte | Campus Virchow-Klinikum, Charité -Universitätsmedizin Berlin, Germany $1 https://orcid.org/0000000240067707
700    1_
$a Froněk, Jiří $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000323793886 $7 xx0061406
700    1_
$a Keller, Theresa $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $u Institute for Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany $1 https://orcid.org/0000000326876660
700    1_
$a Strnad, Pavel $u Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000331649614
700    1_
$a Jiang, Decan $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000305359488
700    1_
$a Gevers, Tom $u Department of Gastroenterology and Hepatology, Maastricht University Medical Center+ (MUMC+), Maastricht, The Netherlands $1 https://orcid.org/0000000230708443
700    1_
$a Koliogiannis, Dionysios $u Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany $1 https://orcid.org/0000000280018547
700    1_
$a Guba, Markus $u Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany $1 https://orcid.org/0000000277788401
700    1_
$a Tolba, Rene H $u Institute for Laboratory Animal Science and Experimental Surgery, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000203833994
700    1_
$a Meister, Franziska A $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000296246042
700    1_
$a Neumann, Ulf P $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000238318917
700    1_
$a Kocik, Matej $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000227309601
700    1_
$a Kysela, Marek $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000214126830
700    1_
$a Sauer, Igor M $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $1 https://orcid.org/000000019355937
700    1_
$a Raschzok, Nathanael $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $u Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Academy, Clinician Scientist Program, Berlin, Germany $1 https://orcid.org/0000000150747063
700    1_
$a Schöning, Wenzel $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000204465126
700    1_
$a Popescu, Irinel $u Department of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania $1 https://orcid.org/0000000228971170
700    1_
$a Tacke, Frank $u Department of Hepatology and Gastroenterology, Campus Charité Mitte | Campus Virchow-Klinikum, Charité -Universitätsmedizin Berlin, Germany $u Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000162060226
700    1_
$a Pratschke, Johann $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $1 https://orcid.org/0000000198391369
700    1_
$a Lurje, Georg $u Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Germany $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany $1 https://orcid.org/0000000196740756
773    0_
$w MED00196656 $t Hepatology communications $x 2471-254X $g Roč. 8, č. 2 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38315126 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155801 $b ABA008
999    __
$a ok $b bmc $g 2081284 $s 1216972
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 8 $c 2 $e 20240203 $i 2471-254X $m Hepatology communications $n Hepatol Commun $x MED00196656
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Archiving options